VanEck Associates’s Astera Labs ALAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.08B Buy
2,237,961
+373,545
+20% +$99.1M 0.66% 28
2026
Q1
$204M Buy
1,864,416
+1,819,597
+4,060% +$259M 0.15% 122
2025
Q4
$7.46M Buy
44,819
+19,156
+75% +$3.2M 0.01% 652
2025
Q3
$5.03M Buy
25,663
+7,340
+40% +$1.21M ﹤0.01% 766
2025
Q2
$1.66M Sell
18,323
-415
-2% -$32.8K ﹤0.01% 973
2025
Q1
$1.12M Buy
18,738
+12,527
+202% +$1.16M ﹤0.01% 1029
2024
Q4
$823K Sell
6,211
-2,603
-30% -$244K ﹤0.01% 1066
2024
Q3
$598K Buy
+8,814
New +$414K ﹤0.01% 1065

Other funds holding ALAB

VanEck Associates's ALAB Position: Q2 2026 in Review

VanEck Associates increased its Astera Labs (ALAB) stake by 20% in Q2 2026, buying an estimated $99.1M and bringing the position to 2,237,961 shares worth $1.08B. The position accounts for 0.66% of the portfolio, ranked #28.

VanEck Associates first reported a position in ALAB in Q3 2024 and has held it in 8 quarters since. 988 funds tracked by Wall St. Rank hold ALAB as of Q2 2026.

  • VanEck Associates held 2,237,961 shares of Astera Labs worth $1.08B as of Q2 2026.
  • VanEck Associates bought 373,545 Astera Labs shares in Q2 2026, an estimated $99.1M.
  • Astera Labs made up 0.66% of VanEck Associates's portfolio in Q2 2026, its #28 holding.
  • VanEck Associates first reported a position in Astera Labs in Q3 2024 and has held it in 8 quarters since.
  • 988 funds tracked by Wall St. Rank held Astera Labs as of Q2 2026.

Based on VanEck Associates's 13F filing for Q2 2026, filed 14 Aug 2026.